hiv patient treatment
TRANSCRIPT
THE IMPACT OF COVID-19 ON HIV PATIENT TREATMENT – A Year in Review
WAVE #4
From March to December 2020, Ipsos ran multiple waves of the HIV COVID-19 Impact study to understand how the pandemic was affecting HIV patient caseload, management, and treatment management in the US.
At the end of the year, the 4th wave of our study revealed another reported decrease in HIV patient caseloads and a return to greater uncertainty, by participating physicians.
www.ipsos.com
ABOUT THE IPSOS HEALTHCARE SERVICE LINEIpsos partners with pharmaceutical, biotech and medical device manufacturers to inspire better healthcare. Operating in over 50 countries, our 1000+ experts support key business decisions for our clients throughout the commercial lifecycle, from early-stage strategy, to launch, to performance optimization. We do this through a uniquely integrated combination of therapeutic and market expertise, gold standard real world evidence, and market-leading custom research approaches – all underpinned by a global footprint and unprecedented access to today’s healthcare stakeholders.
Source: Ipsos US Impact of COVID-19 HIV Study
Fieldwork Dates: March 30, 2020 to April 8, 2020
(Wave 1); May 7, 2020 to May 20, 2020 (Wave 2); July 6, 2020 to July 13, 2020 (Wave 3);
December 1, 2020 to December 17, 2020 (Wave 4)
Country: US
Sample Size: ~100 doctors
Methodology: All data collected online
External source
* Centers for Disease Control and Prevention, COVID-19 Response. COVID-19 Case
Surveillance Public Data Access, Summary, and Limitations (version date: February 28,
2021). Date accessed: March 29, 2021.
Questions asked:
% recorded change in weekly HIV patient caseload
» Prior to the first wave of COVID-19, how many HIV patients did you see in a typical week?
» In the last week, how many HIV patients have you managed both in person and by
telemedicine (where electronic or telecommunication is used to provide care and
services remotely)
» Is this [INCREASE/DECREASE] in the number of HIV patients you saw in the last week vs
what is typical (prior to the first wave of COVID-19), related to the COVID-19 outbreak?
Anticipated future decrease vs increase in HIV caseload
» How do you expect your HIV patient load to change in upcoming weeks?
» Why do you say this?
© Ipsos 2021, all rights reserved. Research conducted in the US.
IPSOSREAL WORLD EVIDENCE
With the emergency approval of several vaccines and the relaxation of state restrictions at the end of 2020, the future impact of COVID-19 on HIV patients remains to be seen.
Contact us to uncover the ongoing impact of COVID-19 on real-world patient management practice: [email protected]
ABOUT THE RESEARCH
WAVE #1 At the beginning of the pandemic, participating physicians stated they saw their HIV patient load decrease and expected this decrease to continue in the coming weeks.
*’Strongly agreed’ is defined as a score of 6 or 7 on a 1-7 rating scalen = 100 physicians
10,000
0
FW PERIOD 03/30 - 04/08
MARCH 2020 APRIL 2020
*7-d
ay M
ovin
g Av
g.
CO
VID
-19
Cas
es
20,000
30,000
8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 157654321
Percentage reported change in weekly patient caseload
“My HIV patients are cancelling
of participating physicians strongly agreed* with this statement
71%
All pts HIV pts
-34%
-45%
Decrease
Increase No change
Don’t know
Expected reported change in HIV caseload in coming weeks
51%
26%
18%6%
scheduled check-up appointments”
WAVE #3 As summer set in, so did positivity, with almost a third of participating physicians expecting their caseload to increase and a lower proportion of physicians compared to previous waves highlighting patients cancelling appointments
*’Strongly agreed’ is defined as a score of 6 or 7 on a 1-7 rating scalen = 100 physicians
30,000
20,000
10,000
0
FW PERIOD 07/06 - 07/13
JUNE 2020 APRIL 2020
*7-d
ay M
ovin
g Av
g.
CO
VID
-19
Cas
es
60,000
50,000
40,000
70,000
23 24 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 3122212019181716
Percentage reported change in weekly patient caseload
“My HIV patients are cancelling
of participating physicians strongly agreed* with this statement
50%
All pts HIV pts
-30%-33%
Decrease
Increase
No change
Don’t know
Expected reported change in HIV caseload in coming weeks
36%
14%
19%
31%
scheduled check-up appointments”
*’Strongly agreed’ is defined as a score of 6 or 7 on a 1-7 rating scale. n = 100 physicians
0
FW PERIOD 12/01 - 12/17
Pfizer-BioNTech COVID-19 Vaccine
Moderna COVID-19 Vaccine93% of participating physicians reported they are
recommending COVID-19 vaccine to HIV patients
NOVEMBER 2020 DECEMBER 2020
*7-d
ay M
ovin
g Av
g. C
OVI
D-1
9 C
ases
300,000
100,000
200,000
22 23 24 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 3021201918171615
Percentage reported change in weekly patient caseload
“My HIV patients are cancelling
of participating physicians strongly agreed* with this statement
41%
All pts HIV pts
-16%
-30%
Decrease
Increase
No change
Don’t know
Expected reported change in HIV caseload in coming weeks
55%6%
13%
26%
scheduled check-up appointments”
WAVE #2 A month later, a quarter of participating physicians were uncertain of what the coming weeks held while almost half expected no change.
Percentage reported change in weekly patient caseload
“My HIV patients are cancelling
of participating physicians strongly agreed* with this statement
59%
All pts HIV pts
Expected reported change in HIV caseload in coming weeks scheduled check-up appointments”
-35%-29%
Decrease
Increase
No change
Don’t know
42%
24%
26%
8%
* ’Strongly agreed’ is defined as a score of 6 or 7 on a 1-7 rating scale. n = 100 physicians
10,000
0
FW PERIOD 05/07 - 05/20
JUNE 2020APRIL 2020 MAY 2020
*7-d
ay M
ovin
g Av
g.
CO
VID
-19
Cas
es
20,000
30,000
30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 6 729282726252423